Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1999
12/09/1999WO1999044943A3 Vectors and viruses used in gene therapy
12/09/1999WO1999043285A3 Sulphonamide derivatives
12/09/1999WO1999032152A3 Methods for delivering pharmaceutical agents to mucosal surfaces
12/09/1999WO1999026583A3 Inhibtion of lipoprotein oxidation
12/09/1999WO1999024066A3 Methods and compositions for enhancing immune response and for the production of in vitro mabs
12/09/1999WO1999006397A3 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists
12/09/1999WO1998025648A3 Use of a texaphyrin in ocular diagnosis and therapy
12/09/1999WO1998005673A8 Methods for purifying nucleic acids
12/09/1999DE19920316A1 Antioxidant medicament containing vitamins and trace elements, useful e.g. for maintaining cellular function and preventing cancer
12/09/1999DE19824972A1 Verwendung von cholesterisch-flüssigkristallinen Zusammensetzungen als UV-Filter in kosmetischen und pharmazeutischen Zubereitungen The use of cholesteric liquid-crystalline compositions as UV filters in cosmetic and pharmaceutical preparations
12/09/1999DE19824922A1 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel New substituted indolinones, their preparation and their use as medicaments
12/09/1999DE19824483A1 Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon Semi-solid aqueous preparations for oral administration of toltrazuril sulfone
12/09/1999DE19820224A1 Bindungspartner und Verfahren zur kompetitiven Hemmung der Bindung zwischen NEF-Protein und Calmodulin, sowie Mittel und Verwendung bei HIV-Erkrankungen Binding partners and methods of competitive inhibition of binding between NEF protein and calmodulin, and means and use in HIV disease
12/09/1999CA2334809A1 Texaphyrin conjugates and uses thereof
12/09/1999CA2334396A1 Heterocyclic thioester and ketone hair growth compositions and uses
12/09/1999CA2334395A1 Small molecule sulfonamide hair growth compositions and uses
12/09/1999CA2334374A1 New 3-aryl propionic acid derivatives and analogs
12/09/1999CA2334299A1 Heterocyclic cis cyclopropane derivatives as melatonergic agents
12/09/1999CA2334258A1 Potassium channel inhibitors
12/09/1999CA2334204A1 Heterocyclic ester and amide hair growth compositions and uses
12/09/1999CA2334186A1 Monoamine oxidase (mao) inhibitors and uses thereof
12/09/1999CA2334117A1 Use of cathepsin s in the diagnosis and treatment of endometriosis
12/09/1999CA2334107A1 New 3-aryl-2-hydroxypropionic acid derivative iii
12/09/1999CA2334032A1 N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
12/09/1999CA2334008A1 N-linked sulfonamide of heterocyclic thioester hair growth compounds and uses
12/09/1999CA2334002A1 N-linked sulphonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres
12/09/1999CA2333997A1 Neurotrophic difluoroamide agents
12/09/1999CA2333994A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
12/09/1999CA2333988A1 Matthiola seed oil, mixtures containing it and use thereof
12/09/1999CA2333964A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
12/09/1999CA2333961A1 Small molecule pipecolic acid derivative hair growth compositions and uses
12/09/1999CA2333960A1 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres
12/09/1999CA2333943A1 Process for preparing crystalline salts of amoxycillin
12/09/1999CA2333903A1 Topical transdermal treatments
12/09/1999CA2333868A1 Pharmaceutical compositions for the treatment of itching comprising pgd2 receptors antagonists
12/09/1999CA2333787A1 Use of sophorolipids comprising diacetyl lactones as agent for stimulating skin fibroblast metabolism
12/09/1999CA2333776A1 Composition based on pentoxifylline and anticytokin
12/09/1999CA2333771A1 Hiv integrase inhibitors
12/09/1999CA2333770A1 Cell adhesion-inhibiting antinflammatory compounds
12/09/1999CA2333756A1 N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors
12/09/1999CA2333752A1 Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue
12/09/1999CA2333726A1 Compositions comprising methotrexate and pentostatin for treating rheumatoid arthritis
12/09/1999CA2333698A1 Pipecolic acid derivative hair growth compositions and uses
12/09/1999CA2333693A1 N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses
12/09/1999CA2333689A1 New neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing said compounds
12/09/1999CA2333688A1 Methods and devices for providing prolonged drug therapy
12/09/1999CA2333679A1 Small molecule carbamate or urea hair growth compositions and uses
12/09/1999CA2333661A1 Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases
12/09/1999CA2333658A1 Fused phenoxymethyl carbapenem antibacterials
12/09/1999CA2333621A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
12/09/1999CA2333620A1 Benzothiazolythiomethyl carbapenem antibacterial
12/09/1999CA2333515A1 Cyanoiminoquinoxaline derivatives
12/09/1999CA2332957A1 Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
12/09/1999CA2332408A1 Combination therapy for treatment of bipolar disorders
12/09/1999CA2331791A1 Aromatic amine derivatives as pharmaceutical agents
12/09/1999CA2331387A1 Methods for the normalization of sexual response and amelioration of long term genital tissue degradation
12/09/1999CA2330833A1 Human minor vault protein p193
12/09/1999CA2330581A1 Stabilization of compositions containing ace inhibitors using magnesium oxide
12/09/1999CA2329527A1 Endometriosis-associated gene
12/09/1999CA2329435A1 Endogenous nitric oxide synthesis under conditions of low oxygen tension
12/09/1999CA2329134A1 Hiv integrase inhibitors
12/09/1999CA2328291A1 Substituted indolinones, the preparation thereof and their use as pharmaceutical compositions
12/09/1999CA2327326A1 Topical administration of oxazolidinones for transdermal delivery
12/08/1999EP0962552A1 A process for the preparation of 4-(des-dimethylamino)-tetracyclines
12/08/1999EP0962463A1 Uncharged morpholino-based polymers having phosphorus-containing chiral intersubunit linkages
12/08/1999EP0962457A1 Piperidones as tachykinin antagonists
12/08/1999EP0962453A1 Histidine derivatives, process for their preparation and their uses
12/08/1999EP0962225A2 Use of phentolamine for the manufacture of a medicament for the treatment of erectile dysfunction
12/08/1999EP0962223A1 Use of cinnamic acid and it's derivatives to stimulate desquamation of the skin and compositions containing it
12/08/1999EP0962222A2 Use of cholesteric liquid crystalline compositions as UV filters in cosmetic and pharmaceutical preparations
12/08/1999EP0962150A2 Fat based food products
12/08/1999EP0961837A1 Three component chimeric antisense oligonucleotides
12/08/1999EP0961826A2 Purification and/or concentration of dna by cross-flow filtration, separation of endotoxins from a nucleic acid preparation
12/08/1999EP0961794A1 Transdermal pressure sensitive adhesive drug delivery system and pressure sensitive adhesive used therein
12/08/1999EP0961779A1 SUBSTITUTED AMINO BICYCLIC-$g(b)-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
12/08/1999EP0961778A1 3-hydroxyacyl-coa dehydrogenase from staphylococcus aureus
12/08/1999EP0961776A1 Tricyclic erythromycin derivatives
12/08/1999EP0961775A2 Purine l-nucleosides, analogs and uses thereof
12/08/1999EP0961772A1 2,4-diaminopyrimidine compounds as anti-cancer agents
12/08/1999EP0961618A1 Novel compounds
12/08/1999EP0961617A1 Leukotriene antagonists for cerebral focal stroke
12/08/1999EP0961616A1 Non-hormonal method of contraception
12/08/1999EP0961615A1 Antimicrobial agent
12/08/1999EP0961614A1 Tricarboxylic acid-containing oxyalkyl esters and uses thereof
12/08/1999EP0961613A1 Methods and compositions for the treatment of bone resorption disorders, including osteoporosis
12/08/1999EP0961612A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
12/08/1999EP0961610A1 Skin preparation
12/08/1999EP0961609A1 Methods for improving the health of hair and scalp
12/08/1999EP0923557A4 Stereoselective deoxygenation reaction
12/08/1999EP0843554B1 Ascorbyl-phosphoryl-cholesterol
12/08/1999EP0784620B1 N-substituted piperidinyl bicyclic benzoate derivatives
12/08/1999EP0771196B1 Excitatory amino acid receptor antagonists
12/08/1999EP0758879B1 Improved anti-dandruff shampoo
12/08/1999EP0730587B1 3-phenyl-2-isoxazolines as antiinflammatory agents
12/08/1999EP0712387B1 2-aminoindans as selective dopamine d3 ligands
12/08/1999EP0678086B1 Compounds having selectivity for retinoid x receptors
12/08/1999EP0674631B1 Substituted pyrazoles as crf antagonists
12/08/1999EP0664780B1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals
12/08/1999EP0660718B1 Method of treating premenstrual syndrome symptomatology with vitamin d or vitamin d and calcium
12/08/1999EP0659177B1 4-oxo-azetidine-2-sulphonic acid amides and their salts, process for their production and their use
1 ... 6398 6399 6400 6401 6402 6403 6404 6405 6406 6407 6408 6409 6410 6411 6412 6413 6414 6415 6416 6417 6418 ... 7860